Trial intelligence / Profile preview

Preference for Enstilar Foam vs Daivobet Gel in Psoriasis

NCT02310646Phase 3Completed

Sponsor
LEO Pharma
Start
Jan 2015
Primary completion
Jul 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of calcipotriol in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started Jan 2015; status: completed.

02

Drugs

calcipotriol
03

Conditions

Psoriasis vulgaris (PV)

Beyond the preview

Go deeper on NCT02310646.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02310646.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call